Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
-2.92%
-2.08%
-3.34%
+9.79%
-19.01%
STE
STERIS plc (Ireland)
$245.21
Chart
$222.77 (+10.07%)
$231.65 (+5.85%)
$221.7 (+10.60%)
$216.5 (+13.26%)
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-2.92%
-2.08%
-3.34%
+9.79%
-19.01%
STE
STERIS plc (Ireland)
Current Price
$245.21
Login to view STERIS plc (Ireland) (STE) recommendation from the last 90 days from financial news and social media.
Chart
$222.77 (+10.07%)
$231.65 (+5.85%)
$221.7 (+10.60%)
$216.5 (+13.26%)
STE Latest Headlines
Are Options Traders Betting on a Big Move in STERIS (STE) Stock?. Investors need to pay close attention to STERIS (STE) stock based on the movements in the options market lately.
Wed May 21, 2025
Steris Stock: A Deep Dive Into Analyst Perspectives (4 Ratings). In the last three months 4 analysts have published ratings on Steris (NYSE:) offering a diverse range of perspectives from ish to bearish.The following table provides a quick overview of their recent ratings highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.0310000100020000100000000In the assessment of 12-month price targets analysts unveil insights for Steris presenting an averag
Mon May 19, 2025
Steris Stock: A Deep Dive Into Analyst Perspectives (4 Ratings). In the last three months 4 analysts have published ratings on Steris (NYSE:) offering a diverse range of perspectives from ish to bearish.The following table provides a quick overview of their recent ratings highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.0310000100020000100000000In the assessment of 12-month price targets analysts unveil insights for Steris presenting an averag
Mon May 19, 2025
Steris GAAP EPS of $1.48 misses by $0.43 revenue of $1.5B beats by $30M.
Wed May 14, 2025
Steris GAAP EPS of $1.48 misses by $0.43 revenue of $1.5B beats by $30M.
Wed May 14, 2025
STERIS Announces Financial Results for Fiscal 2025 Fourth Quarter and Full Year. DUBLIN IRELAND May 14 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (STERIS or the Company) today announced financial results for its fiscal 2025 fourth quarter and full year ended March 31 2025. Total revenue from continuing operations for the fourth quarter of fiscal 2025 increased 4% to $1.5 billion compared with $1.4 billion in the fourth quarter of fiscal 2024. Constant currency organic revenue growth from co
Wed May 14, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Hover over the category for more information
